Alternancia de la Onda T como marcador de riesgo en la miocardiopatía hipertrófica: Una revisión sistemática de la literatura

Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is characterized by the existence of a ventricle left thickened but not dilated in the absence of another heart disorder or systemic that can produce hypertrophy (eg, aortic valve stenosis, hypertension arterial or some forms of the athlete’s heart). Since its description in 1958, This entity has received a variety of names, including: hypertrophy Asymmetric septal, idiopathic hypertrophic subaortic stenosis, subaortic stenosis dynamics and obstructive hypertrophic cardiomyopathy. The World Organization of Health (WHO) adopted the term hypertrophic cardiomyopathy (HCM), which results in more accurate to describe the primary hypertrophy that can occur with obstruction dynamics of the left ventricle outflow tract or not.



Vicente F. Alcalde Martínez
Miriam Jiménez Fernández
Norberto Herrera Gómez